Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China · Delayed Price · Currency is CNY 36.06
+0.59 (1.66%)
At close: Jun 2, 2026
SHA:688163 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 48.6 | 51.79 | 44.29 | 38.77 | 64.2 | 76.48 |
Depreciation & Amortization | 19.13 | 19.13 | 20.1 | 17.16 | 14.9 | 15.04 |
Other Amortization | 0.4 | 0.4 | 0.24 | 0.24 | 0.24 | 0.24 |
Loss (Gain) From Sale of Assets | -0.08 | -0.08 | -1.44 | - | - | 0.25 |
Asset Writedown & Restructuring Costs | 0.06 | 0.06 | 1.03 | 0.02 | -0.95 | 1.02 |
Loss (Gain) From Sale of Investments | -10.59 | -10.59 | 1.01 | -10.33 | -16.04 | 0.79 |
Provision & Write-off of Bad Debts | 0.1 | 0.1 | 0.74 | 0.79 | -0.53 | 0.6 |
Other Operating Activities | 14.87 | 2.51 | 3.21 | 4.39 | 0.19 | 0.83 |
Change in Accounts Receivable | -8.49 | -8.49 | -10.42 | -22.99 | 3.2 | -4.48 |
Change in Inventory | -1.83 | -1.83 | -1.56 | 6.13 | -4.33 | -0.48 |
Change in Accounts Payable | 6.04 | 6.04 | -4.32 | -0.5 | 7.87 | 1 |
Change in Other Net Operating Assets | - | - | - | - | - | 0.79 |
Operating Cash Flow | 69.7 | 60.53 | 50.25 | 32.82 | 67.91 | 92.29 |
Operating Cash Flow Growth | 36.35% | 20.46% | 53.12% | -51.67% | -26.41% | -6.17% |
Capital Expenditures | -78.52 | -59.61 | -59.37 | -28.67 | -26.46 | -27.61 |
Sale of Property, Plant & Equipment | 0.13 | 0.13 | 0.01 | 0.02 | - | 0.33 |
Investment in Securities | -264.69 | -124.99 | 70.83 | -305 | -349.85 | -65 |
Other Investing Activities | 10.5 | 10.38 | 5.27 | 17.71 | 15.89 | 1.76 |
Investing Cash Flow | -332.59 | -174.09 | 16.73 | -315.94 | -360.42 | -90.52 |
Long-Term Debt Repaid | - | -0.69 | -1.15 | -0.69 | -1.34 | -1.31 |
Net Debt Issued (Repaid) | -0.69 | -0.69 | -1.15 | -0.69 | -1.34 | -1.31 |
Issuance of Common Stock | - | - | - | - | 790.61 | - |
Common Dividends Paid | -34.63 | -34.63 | -34.63 | -81.16 | -97.39 | - |
Dividends Paid | -34.63 | -34.63 | -34.63 | -81.16 | -97.39 | - |
Other Financing Activities | -0.12 | - | - | - | - | -2.7 |
Financing Cash Flow | -35.44 | -35.32 | -35.77 | -81.84 | 691.87 | -4.01 |
Foreign Exchange Rate Adjustments | 0.04 | 0.05 | -0.03 | 0.16 | 0.49 | -0.12 |
Net Cash Flow | -298.29 | -148.83 | 31.19 | -364.81 | 399.85 | -2.36 |
Free Cash Flow | -8.83 | 0.93 | -9.12 | 4.15 | 41.46 | 64.68 |
Free Cash Flow Growth | - | - | - | -90.00% | -35.91% | -19.58% |
Free Cash Flow Margin | -4.46% | 0.47% | -4.68% | 2.18% | 23.79% | 30.99% |
Free Cash Flow Per Share | -0.10 | 0.01 | -0.08 | 0.04 | 0.41 | 0.80 |
Cash Income Tax Paid | 18.3 | 18.63 | 13.33 | 25.02 | 12.86 | 16.85 |
Levered Free Cash Flow | -21.22 | -10.27 | -23.72 | -3.9 | 32.16 | 34.48 |
Unlevered Free Cash Flow | -21.11 | -10.16 | -23.45 | -3.5 | 32.58 | 34.93 |
Change in Working Capital | -2.79 | -2.79 | -18.93 | -18.22 | 5.9 | -2.96 |